These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31593606)

  • 21. Heritable factors distinguish two types of alopecia areata.
    Price VH; Colombe BW
    Dermatol Clin; 1996 Oct; 14(4):679-89. PubMed ID: 9238326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulse corticosteroid therapy for alopecia areata: long-term outcome after 10 years.
    Staumont-Sallé D; Vonarx M; Lengrand F; Segard M; Delaporte E
    Dermatology; 2012; 225(1):81-7. PubMed ID: 22964518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma in alopecia areata.
    Arca E; Muşabak U; Akar A; Erbil AH; Taştan HB
    Eur J Dermatol; 2004; 14(1):33-6. PubMed ID: 14965793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review.
    Nowaczyk J; Makowska K; Rakowska A; Sikora M; Rudnicka L
    Dermatol Ther (Heidelb); 2020 Jun; 10(3):387-399. PubMed ID: 32270396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alopecia areata: a long term follow-up study of 191 patients.
    Tosti A; Bellavista S; Iorizzo M
    J Am Acad Dermatol; 2006 Sep; 55(3):438-41. PubMed ID: 16908349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulse methylprednisolone therapy for the treatment of extensive alopecia areata.
    Açıkgöz G; Ozmen I; Cayırlı M; Yeniay Y; Köse O
    J Dermatolog Treat; 2014 Apr; 25(2):164-6. PubMed ID: 23336179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Relapse Rates Despite Early Intervention with Intravenous Methylprednisolone Pulse Therapy for Severe Childhood Alopecia Areata.
    Smith A; Trüeb RM; Theiler M; Hauser V; Weibel L
    Pediatr Dermatol; 2015; 32(4):481-7. PubMed ID: 25872976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous methylprednisolone pulse therapy in severe alopecia areata.
    Senila SC; Danescu SA; Ungureanu L; Candrea E; Cosgarea RM
    Indian J Dermatol Venereol Leprol; 2015; 81(1):95. PubMed ID: 25566921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review.
    Papadimitriou DT; Bothou C; Dermitzaki E; Alexopoulos A; Mastorakos G
    World J Clin Pediatr; 2021 Nov; 10(6):192-199. PubMed ID: 34868895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of hair growth in alopecia totalis with diphencyprone sensitization.
    Monk B
    Clin Exp Dermatol; 1989 Mar; 14(2):154-7. PubMed ID: 2598490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical and intralesional therapies for alopecia areata.
    Alkhalifah A
    Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study.
    Lalosevic J; Gajic-Veljic M; Bonaci-Nikolic B; Nikolic M
    Dermatol Ther; 2015; 28(5):309-17. PubMed ID: 26179196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study.
    Meaux TA; McMahon PM; Jones GN; Bush AE; Kennedy JJ; Poche GW
    Ochsner J; 2021; 21(2):139-142. PubMed ID: 34239372
    [No Abstract]   [Full Text] [Related]  

  • 35. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology.
    Taylor CR; Hawk JL
    Br J Dermatol; 1995 Dec; 133(6):914-8. PubMed ID: 8547044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Methotrexate Combined with Low- to Moderate-Dose Corticosteroids for Severe Alopecia Areata.
    Anuset D; Perceau G; Bernard P; Reguiai Z
    Dermatology; 2016; 232(2):242-8. PubMed ID: 26735937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice.
    Gilhar A; Pillar T; Assay B; David M
    Br J Dermatol; 1992 Feb; 126(2):166-71. PubMed ID: 1536782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
    Putterman E; Castelo-Soccio L
    J Am Acad Dermatol; 2018 Jun; 78(6):1207-1209.e1. PubMed ID: 29754888
    [No Abstract]   [Full Text] [Related]  

  • 39. Five-year experience in the treatment of alopecia areata with DPC.
    El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of alopecia areata.
    Fiedler VC; Alaiti S
    Dermatol Clin; 1996 Oct; 14(4):733-7. PubMed ID: 9238331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.